These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14503949)

  • 1. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
    Contasta I; Berghella AM; Pellegrini P; Adorno D
    Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules.
    Contasta I; Pellegrini P; Berghella AM; Adorno D
    Cancer Biother Radiopharm; 2001 Feb; 16(1):63-71. PubMed ID: 11279799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network.
    Contasta I; Berghella AM; Pellegrini P; Del Beato T; Casciani CA; Adorno D
    Cancer Biother Radiopharm; 1999 Dec; 14(6):465-75. PubMed ID: 10850333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the soluble CD30 serum level in colorectal cancer: a possible marker for a patient subset which could benefit from IL-2 biotherapy.
    Dle Beato T; Berghella AM; Pellegrini P; Domenico A; Casciani CU
    Cancer Biother Radiopharm; 1997 Oct; 12(5):297-304. PubMed ID: 10851480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides.
    Schönermarck U; Csernok E; Trabandt A; Hansen H; Gross WL
    Clin Exp Rheumatol; 2000; 18(4):457-63. PubMed ID: 10949720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1 and Th2 cytokine modulation by IL-10/IL-12 imbalance in autoimmune haemolytic anaemia (AIHA).
    Fagiolo E; Toriani-Terenzi C
    Autoimmunity; 2002 Feb; 35(1):39-44. PubMed ID: 11908705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments.
    Pellegrini P; Contasta I; Berghella AM; Del Beato T; Casciani CU; Adorno D
    Cancer Biother Radiopharm; 2000 Jun; 15(3):267-78. PubMed ID: 10941534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
    Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
    J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors.
    Inagaki A; Ishida T; Ishii T; Komatsu H; Iida S; Ding J; Yonekura K; Takeuchi S; Takatsuka Y; Utsunomiya A; Ueda R
    Int J Cancer; 2006 Jun; 118(12):3054-61. PubMed ID: 16425276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
    Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
    J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA).
    Ruschpler P; Stiehl P
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):285-93. PubMed ID: 12030433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CD30 transcripts with Th1 responses and proinflammatory cytokines in patients with end-stage renal disease.
    Velásquez SY; Opelz G; Rojas M; Süsal C; Alvarez CM
    Hum Immunol; 2016 May; 77(5):403-10. PubMed ID: 26970513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer.
    Contasta I; Pellegrini P; Berghella AM; Del Beato T; Canossi A; Di Rocco M; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Dec; 11(6):373-83. PubMed ID: 10851498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the T-helper cell 1/T-helper cell 2 balance of peripheral T-helper cells after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Mukai M; Bohgaki T; Kondo M; Notoya A; Kohno M
    Ann Hematol; 2001 Dec; 80(12):715-21. PubMed ID: 11797111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.